Navigation Links
GeoVax Labs, Inc. Comments on Discontinuance of Merck's HIV Vaccine Trial
Date:9/24/2007

ATLANTA, Sept. 24 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX)

On September 21, 2007, Merck & Co., Inc. announced their candidate AIDS vaccine failed to provide protection in a human study designed to test for efficacy.

In this Merck trial involving high risk volunteers, an equal number of people received either placebo or AIDS vaccine. The independent Data Safety Monitoring Board recommended that the trial be stopped because it was not reaching its efficacy endpoints.

Merck has stopped further vaccinations but will continue to follow volunteers in the trial. The Merck trial was being carried out in conjunction with the HIV Vaccine Trials Network (HVTN), a prestigious trial network funded by the US National Institutes of Health.

Don Hildebrand, GeoVax's President and CEO, commented, "We, along with the rest of the scientific community, are disappointed in the clinical failure of Merck's HIV vaccine trial. We all share the same goal of finding a safe and effective vaccine to address the devastation of the HIV/AIDS epidemic. We, however, would like to take this opportunity to highlight important differences between our vaccine technology and the technology used in the Merck trial."

GeoVax AIDS vaccines advancing in human trials represent a significantly different vaccine approach, vaccine composition and results to date than the Merck vaccine.

1) Prototypes for the GeoVax vaccines were selected from a series of trials in non-human primates for their ability to protect against the development of AIDS when vaccinated individuals were administered an AIDS causing virus. At each major step along the development pathway, GeoVax vaccines providing the best protection against AIDS were moved forward.

2) GeoVax AIDS vaccines demonstrated excellent protective results in non- human primate models, much better protective results than reported for Merck's vaccine in similar models. GeoVax AIDS vaccines pro
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
2. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
3. From Clinical Cancer Research: Rethinking Therapeutic Cancer Vaccine Trials
4. DOR BioPharma Announces Publication Describing Results of Its Multivalent Botulinum Toxin Vaccine BT-VACC
5. Vaccine Can Prevent Cervical Cancer and Precancerous Lesions
6. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
7. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
8. HepaLifes PBS-1 Cells for Influenza Vaccine Production Prove Superior at International Conference
9. New Flu Vaccine from PepTcell Could Provide Immunity Against All Strains of Influenza Virus
10. Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure Reduction During Important Early Morning Period When Most Adverse Cardiovascular Events Occur
11. New Flu Vaccine From PepTcell Could Provide Immunity Against All Strains of Influenza Virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... April 17, 2015 /CNW/ - The issue: ... is voluntarily recalling one lot (lot 710535) of Clavulin-400 (70mL) ... pieces had been found in one bottle of the  product. ... this time. Clavulin-400 is an oral antibiotic used ... treat various bacterial infections. Clavulin-400 comes as a powder in ...
(Date:4/17/2015)... N.C. , April 17, 2015 ... the Integrated Embolic Protection™ filter platform for angioplasty ... of a $5.6 million Series B financing round ... venture firm with a focus on medical devices, ... The round also included Mountain Group Partners, Lookout ...
(Date:4/17/2015)... N.C. , April 17, 2015  Regulatory leaders ... newly released bipartisan discussion draft called "21 st ... is planned to be taken up by Congress soon ... pharmaceutical and medical device products are developed and marketed ... that reason, many companies have begun to consider how ...
Breaking Medicine Technology:Advisory - Clavulin-400 liquid oral antibiotic: One lot recalled after glass pieces found in one bottle 2Contego Medical Closes $5.6 Million in Series B Funding 2Contego Medical Closes $5.6 Million in Series B Funding 321st Century Cures: A Regulatory Game-Changer for the Pharmaceutical Industry 2
... Oct. 18, 2011 President Barack Obama named Sumita ... Career Award for Scientists and Engineers (PECASE) on Sept. ... bestowed upon science and engineering professionals in the early ... of medical engineering at University of California Santa Barbara, ...
... ICAP Patent Brokerage , a division of ICAP ... patent auction firm, is offering for sale a novel ... of Posterolateral Lumbar Disc Arthroplasty (PLDA). The portfolio includes ... and methods of implantation. (Logo:   http://photos.prnewswire.com/prnh/20100614/CG20517LOGO ...
Cached Medicine Technology:President Obama Presents Early Career Award to Dr. Sumita Pennathur 2Novel Medical Device Patent Portfolio for Posterolateral Lumbar Disc Arthroplasty Offered for Sale by ICAP Patent Brokerage 2
(Date:4/18/2015)... Carinsurancesavings.biz has released a new blog post explaining why ... , Spring can be a great season for ... they compare the newest policies before deciding on a ... Spring car insurance offers by reading the newly released ... more and more popular. Many insurance brokerage websites like ...
(Date:4/18/2015)... Review of Ophthalmology magazine and Abbot Medical ... program for cataract surgeons attending the American Society of ... eye surgeon Jeffrey L. Martin, MD will serve as ... is the Managing Partner of North Shore Eye Care. ... to lead this year’s discussion on the latest breakthroughs ...
(Date:4/18/2015)... Patients who undergo radiation for a hematologic ... life, but the disease is likely to differ in ... radiation. Surviving Mesothelioma has just posted the details of ... to read it now. , Scientists from China, ... patients who had both a hematologic cancer (like lymphoma ...
(Date:4/18/2015)... On April 14th, 2015, Symantec released Volume 20 ... “exposes a tactical shift by cyberattackers.” With everything from frightening ... 2014 - almost a million a day - to how ... and patched by prominent manufacturers – as long as 204 ... a digital world can be fraught with peril, and that ...
(Date:4/18/2015)... French physician and gastronome Anthelme Brillat-Savarin understood the ... “Tell me what you eat, and I will tell ... stress or sadness has often been attributed to women, ... collected from their Emotional Eating Test reveals ... for different reasons. , Collecting data from 521 emotional ...
Breaking Medicine News(10 mins):Health News:Auto Insurance Plans Are Cheaper During Spring! 2Health News:Dr. Jeffrey Martin Invited to Share Latest Breakthroughs in Cataract Care During Roundtable Discussion at National 2015 ASCRS Meeting In San Diego 2Health News:New Study Examines Relationship Between Radiation for Hematologic Cancers and Development of Mesothelioma, According to Surviving Mesothelioma 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 3Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 4Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 5Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 2Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 3Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 4Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 5Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 6
... the University of East Anglia in Norwich and Kings College ... could soon be used to find out not only the ... but also identify diseases. ,Lead researcher, David A. ... people gain information about the lifestyle of the person whose ...
... images of the physical changes in brain cells thought to ... ,Earlier studies have established that a physiological effect ... ,In neuroscience, LTP is an increase in the ... several days. It is widely considered one of the major ...
... new study has found that no other lifestyle factors impact ... study in the May issue of the Journal of Periodontology ... health. ,As a part of the study ... from 1999 to 2003 in an attempt to evaluate the ...
... -natural pine bark extract from the French maritime pine ... causes to the heart. ,The study ... female mice (18 months old) were randomly divided into ... receiving L-NAME only (a substance which causes arterial constriction) ...
... and alarmed, a good number of yoga enthusiasts and experts ... yoga overseas. ,Reacting to recent reports of yet ... here feel that the very idea of patenting knowledge like ... is highly unjustified and when it comes to patenting yoga, ...
... because not enough is known about their long-term safety ... in todays British Medical Journal. ,Functional ... quality of life and/or well-being, for example, yoghurts or ... heart. ,These foods are rapidly increasing ...
Cached Medicine News:Health News:Now Fingerprints can Be Used to Detect Drugs and Diseases Instead of Blood Samples 2Health News:Memory Loss Linked to Cognitive Disorders 2Health News:Impact of Periodontal Health High With Smoking and Sleeping 2Health News:Natural Pine Bark Extract Reduces Heart Failure Risk 2Health News:Yoga Enthusiasts Oppose Patenting Yoga Overseas 2Health News:Functional Foods Must Be Monitored to Assess Their Long-term Safety and Effectiveness 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: